As early as the 1920s, and subsequently in the 1959 Build and Blood Pressure Study (S1. 5-
1) of almost 5 million adults insured between 1934 and 1954, a strong direct relationship …

The National High Blood Pressure Education Program presents the complete Seventh
Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment …

The racial disparity in hypertension and hypertension-related outcomes has been
recognized for decades with African Americans with greater risks than caucasians. Blood …

Context Antihypertensive therapy is well established to reduce hypertension-related
morbidity and mortality, but the optimal first-step therapy is unknown. Objective To determine …

The goal of antihypertensive therapy is to abolish the risks associated with blood pressure
(BP) elevation without adversely affecting quality of life. Drug selection is based on efficacy …

Background Characteristics such as age and race are often cited as determinants of the
response of blood pressure to specific antihypertensive agents, but this clinically important …

Since the first International Society on Hypertension in Blacks consensus statement on the
“Management of High Blood Pressure in African American” in 2003, data from additional …

Background: Heart failure in blacks has been associated with a poorer prognosis than in
whites. In such diseases as hypertension, blacks show pathophysiological differences and …

Angiotensin II plays a central role in the regulation of systemic arterial pressure through its
systemic synthesis via the renin-angiotensin-aldosterone cascade. It acts directly on …

ContextFew cardiovascular outcome data are available for blacks with hypertension treated
with angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers (CCBs) …